Stopping antihypertensive Treatment amOng hypertensive patients in Primary care: The STOP-Trial
About one-third of individuals on monotherapy or low-dose dual AHT who discontinued treatment maintained controlled BP after one year. Discontinuing AHT may be considered in selected individuals with HBPM below 120 mmHg, provided close BP monitoring is performed, particularly within the first year of AHT withdrawal. Clinicaltrial.gov registration number: NCT02268071.
Authors
- Nicolas Girerd (ORCID: https://orcid.org/0000-0002-3278-2057)
- Marilucy Lopez‐Sublet
- Kévin Duarte (ORCID: https://orcid.org/0000-0002-0292-0498)
- Faiez M. Zannad (ORCID: https://orcid.org/0000-0001-7456-1570)
- Patrick Rossignol (ORCID: https://orcid.org/0000-0003-4470-7932)
- João Pedro Ferreira (ORCID: https://orcid.org/0000-0002-2304-6138)
- J-M Boivin
Institutions
- Inserm (FR)
- Princess Grace Hospital Centre (MC)
- Université Sorbonne Paris Nord (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Administração Regional de Saúde de Lisboa e Vale do Tejo (PT)
- Hôpital Avicenne (FR)
- French Clinical Research Infrastructure Network (FR)
- Université de Lorraine (FR)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2025-08-21
- DOI
- https://doi.org/10.1093/eurjpc/zwaf511
- Citations
- 3
- Primary Topic
- Blood Pressure and Hypertension Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.16